GSK CEO warns UK drug pricing reforms threaten life sciences
Emma Walmsley warns Britain's life sciences industry faces 'existential threat' from proposed drug pricing reforms that could drive investment and research overseas.
Emma Walmsley warns Britain's life sciences industry faces 'existential threat' from proposed drug pricing reforms that could drive investment and research overseas.
Groundbreaking neuroscience research uncovers how sleep deprivation hijacks your brain's attention networks, causing frustrating mental lapses and concentration failures even during simple tasks.